Background
==========

Benign tumors of nasopharynx are rare since nasopharynx is a common site for malignant tumors. Pleomorphic adenoma is the most common benign tumor of the major and minor salivary glands, but rarely found in the nasopharynx. In this case report, we present a case of a large pleomorphic adenoma arising in the nasopharynx and extending to oropharynx that was diagnosed and managed as squamous cell carcinoma.

Case presentation
=================

In Sep 2007, a 35-year-old male presented with a progressive nasal obstruction associated with left aural fullness, hearing loss and hyponasal speech for the past five months. Later, the patient saw a mass pushing the soft palate downwards and began having difficulty in swallowing solid food. On examination, there was a mass behind and above the soft palate, which appeared to be arising from nasopharynx. Neck examination was found normal. Past history included a pyelolithotomy and gastrojujenostomy for duodenal ulcer.

A fine needle aspiration biopsy (FNAB) of the mass was done intra-orally and microscopic examination revealed a poor smear with scanty cells. The pathologist suggested the possibility of a squamous cell carcinoma and advised a direct biopsy for definitive diagnosis. On 19^th^Sep 2007, computed tomographic (CT) scan of the neck revealed a large mass of heterogeneous density involving the fossa of Rosenmuller, and extending to the valleculla through parapharyngeal space. The mass had heterogeneous contrast enhancement with central necrosis (Fig [1](#F1){ref-type="fig"}). Based on these features, radiologist suggested a malignant tumor of the nasopharynx.

![**On 19^th^Sep 2007, pre-radiotherapy contrast CT scan found heterogeneous enhanced tumor in the nasopharynx with extension up to parapharyngeal area**. The tumor had multiple necrotic areas with largest area in its lower part.](1472-6815-10-2-1){#F1}

A radiation oncologist evaluated the patient and investigations, and began radical chemo-radiation. However, the tumor did not regress despite receiving 20 Gray of radiation, and this led to a suspicion of a benign growth. On 25^th^March 2008, a fresh CT scan (Fig [2](#F2){ref-type="fig"}) was done and it showed nasopharyngeal tumor with same features as pre radiotherapy but increased considerably as compared to earlier CT scan. Since there was no histopathological evidence of the carcinoma, the intra-oral incisional biopsy was done and was found to be suggestive of a pleomorphic adenoma. A surgical intervention was planned, and tumor was excised by transpalatal approach under general anesthesia. Histological examination of the excised tumor confirmed a pleomorphic adenoma with no evidence of malignancy (Fig [3](#F3){ref-type="fig"}). The patient recovered well without any complication and had no recurrence in follow up of 1 year.

![**On 25^th^March 2008, post-radiotherapy CT scan showed same heterogeneous enhanced tumor of nasopharynx but increased considerably as compared to earlier CT scan (Fig 1)**.](1472-6815-10-2-2){#F2}

![**Photomicrograph of pleomorphic adenoma showing epithelial component (marked as \'1\') consisting of acini, duct, sheets and cords, and mesenchymal component consisting of myxoid (marked as \'2\') and chondroid areas (marked as \'3\')**. (H & E × 100).](1472-6815-10-2-3){#F3}

Discussion
==========

In retrospective review of the CT scans, there could be a possibility of tumor arising in the parapharyngeal space and extending to nasopharynx but clinical progression of the tumor and normal neck examination was in favor of nasopharyngeal origin. Parapharyngeal benign tumors have classical features of sub mucosal swelling in the lateral pharyngeal wall with or without extension to retromandibular area or the submandibular triangle, and bimanually ballot ability. These tumors can have additional features of otalgia, neuralgia, trismus, and paresis/palsies of 9^th^, 10^th^or 11^th^cranial nerves \[[@B1],[@B2]\].

The fossa of Rosenmuller is a common site of squamous cell carcinoma of the nasopharynx. Nasal obstruction, epistaxis and adenopathy are common symptoms of nasopharyngeal carcinoma; however, the exact diagnosis of nasopharyngeal growth can be made only by an accurate histopathology. The exact site of tumor origin in this case report could be debatable but we present this case because a major mistake occurred by not performing a direct tumor biopsy before starting chemo-radiation.

Palate, nasal cavity and nasopharynx have abundant minor salivary glands and pleomorphic adenoma is the most common benign tumor of these glands. Pleomorphic adenoma arising in the nasal cavity has scanty or absent cartilaginous component which can make histological diagnosis difficult \[[@B3]\]. Compagno and Wong \[[@B4]\] reported that microscopically pleomorphic adenoma of the nasal cavity resembles mixed tumor of the major salivary glands but due to high epithelial cellularity and little stromal component these benign tumor can be mistaken for malignant epithelial neoplasm. Lam *et al*. \[[@B5]\] found skeletal muscle differentiation in pleomorphic adenoma of the nasopharynx which can simulate rhabdomyosarcoma.

Malignant tumors comprise about 40-50% in all the minor salivary gland tumors (7% are carcinoma ex pleomorphic adenoma) \[[@B6]-[@B9]\]. Pleomorphic adenoma has three malignant varieties: carcinoma ex pleomorphic adenoma, carcino-sarcoma and metastasizing pleomorphic adenoma. Carcinoma ex pleomorphic adenoma is a rare mixed tumor developing from the epithelial component of the pleomorphic adenoma \[[@B9]-[@B11]\]. The malignant transformation in the pleomorphic adenoma has been linked to recurrence and multiple excisions \[[@B12],[@B13]\], laminin, and collagen IV deposition \[[@B14],[@B15]\]. Recently \[[@B16]\], it has been found that loss of β-catenin adhesion molecule is one of the factors responsible for development of pleomorphic adenoma and cytoplasmic accumulation of this molecule causes malignant transformation in pleomorphic adenoma.

CT scan does not provide significant differentiation between carcinoma ex pleomorphic adenoma (CXPA) and benign pleomorphic adenoma as CXPA can have malignant appearance or benign features similar to pleomorphic adenoma. On MRI, low T1 and T2-weighted signal intensity has been suggested as an indicator for carcinoma ex pleomorphic adenoma \[[@B17]\].

An extensive literature review revealed only five cases of pleomorphic adenoma arising in the nasopharynx \[[@B5],[@B18]-[@B21]\]. Roh *et al*. \[[@B20]\] excised a pleomorphic adenoma of nasopharynx in a 61-year-old female by endoscope. They advocated use of endoscope in these cases to avoid injury to eustachian tube. Lee *et al*. \[[@B21]\] reported a similar case in an elderly patient who had otalgia, aural fullness and tinnitus. The tumor was excised endoscopically and patient had no recurrence.

Although, radiotherapy is indicated in recurrent pleomorphic adenoma but in our case, diagnosis of carcinoma was made on cytology alone. The patient received chemo-radiation but tumor increased in size, and then tumor was found to be a benign pleomorphic adenoma. Possibly, myoepithelial or epithelial atypia with keratin debris in pleomorphic adenoma (Fig [4](#F4){ref-type="fig"}) led to cytological diagnosis of carcinoma. To make the issue more complex, there could be a possibility that the adenoma was undergoing malignant transformation and these changes were picked up in the cytology. After radiotherapy, malignant part disappeared and consequently we did not find any evidence of malignancy in the excised pleomorphic adenoma.

![**Photomicrograph of pleomorphic adenoma showing keratin plug of its epithelial component**. (H & E × 100).](1472-6815-10-2-4){#F4}

Conclusion
==========

The pleomorphic adenoma was undergoing malignant changes or it was a misdiagnosis, we could not ascertain the exact pathology, as we had no pre-radiotherapy histopathological evidence. However, who was at fault: clinician by not following the advice of pathologist for a direct biopsy, or oncologist who started chemo-radiation without any histopathological proof? We cannot blame anyone rather than ourselves as the clinician are the most accountable.

In this case report, many questions remained unanswered but a lesson learnt was:

1\. The possibility of benign tumor should be kept in the differential diagnosis of nasopharyngeal tumor without adenopathy.

2\. Clinician should follow pathologist\'s advice, carefully interpret the cytological diagnosis, and consult the pathologist, whenever in doubt.

3\. An adequate tissue specimen should be obtained especially for cytological diagnosis as pleomorphic adenoma can simulate as a carcinoma.

4\. No patient should be taken for chemo-radiation without any histopathological evidence.
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